Amtagvi®
Company
Iovance Biotherapeutics
Use
Treatment of unresectable or metastatic melanoma.
Features
Tumor-derived autologous T cell immunotherapy, first one-time, individualized T cell therapy for solid tumors
NIH Contribution
Development of the HPV-specific TILs for cancer therapy and associated research.
HHS Institute/Agency
NCI
Inventor(s)
Hinrichs, C. et al.
Year
2024
